{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:31:56Z","timestamp":1792834316048,"version":"4.5.0"},"reference-count":142,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA269607"],"award-info":[{"award-number":["RO1CA269607"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Glioblastoma (GBM), the most common, invasive, and chemoresistant form of adult primary brain cancer, is characterized by rapid cell proliferation, local invasiveness, and resistance to chemotherapy (e.g., temozolomide (TMZ)) and radiation therapy. Curcumin, a bioactive polyphenol derived from Curcuma longa, has exhibited exceptional anti-cancer properties, including anti-proliferative, pro-apoptotic, anti-inflammatory, and anti-angiogenic activities in a wide range of cancer models, including GBM. However, the clinical application of curcumin has been seriously limited by several challenges, including low water solubility, low bioavailability, rapid systemic clearance, and poor blood\u2013brain barrier (BBB) penetration. To overcome these challenges, several nanocarrier systems to produce nanocurcumin have been developed, including liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, and micelles. These nanoformulations improve the solubility, stability, systemic circulation, and target-directed delivery of curcumin to glioma cells, thereby resulting in a high level of accumulation in the glioma microenvironment. On the other hand, this work is devoted to the potential of curcumin and nanocurcumin for the treatment of GBM. The article provides a detailed review of the major molecular targets of curcumin, such as NF-\u03baB, STAT3, PI3K\/AKT\/mTOR, and p53 signaling pathways, as well as recent advancements in nanotechnology-based delivery platforms that improve drug delivery across the BBB and their possible clinical translation. We also include a thorough examination of the issues, limitations, and potential opportunities associated with the clinical advancement of curcumin-based therapeutics for GBM.<\/jats:p>","DOI":"10.3390\/nu18020194","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:34:12Z","timestamp":1767778452000},"page":"194","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Advances of Curcumin and Nanocurcumin in Glioblastoma: Molecular Targets, Bioavailability, and Drug Delivery"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-3694","authenticated-orcid":false,"given":"Md Ataur","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh Kumar","family":"Yadab","sequence":"additional","affiliation":[{"name":"Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meser M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sipos, D., Raposa, B.L., Freihat, O., Simon, M., Mekis, N., Cornacchione, P., and Kov\u00e1cs, \u00c1. (2025). Glioblastoma: Clinical presentation, multidisciplinary management, and Long-Term outcomes. Cancers, 17.","DOI":"10.3390\/cancers17010146"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/crst.crst_250_23","article-title":"Glioblastoma multiforme-a rare type of cancer: A narrative review","volume":"7","author":"Bijalwan","year":"2024","journal-title":"Cancer Res. Stat. Treat."},{"key":"ref_3","first-page":"e66830","article-title":"A case report on a common tumour with an uncommon presentation: Glioblastoma","volume":"16","author":"Munagama","year":"2024","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Duan, M., Cao, R., Yang, Y., Chen, X., Liu, L., Ren, B., Wang, L., and Goh, B.-C. (2024). Blood\u2013brain barrier conquest in glioblastoma nanomedicine: Strategies, clinical advances, and emerging challenges. Cancers, 16.","DOI":"10.20944\/preprints202409.0186.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12013-024-01477-5","article-title":"Curcumin, a bioactive compound of Turmeric (Curcuma longa) and its derivatives as \u03b1-amylase and \u03b1-glucosidase inhibitors","volume":"83","author":"Roney","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nowacka, A., Zi\u00f3\u0142kowska, E., Smuczy\u0144ski, W., Bo\u017ci\u0142ow, D., and \u015aniegocki, M. (2025). Potential of Curcumin and Its Analogs in Glioblastoma Therapy. Antioxidants, 14.","DOI":"10.3390\/antiox14030351"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.2174\/0929867330666230522144312","article-title":"Curcumin and its derivatives targeting multiple signaling pathways to elicit anticancer activity: A comprehensive perspective","volume":"31","author":"Fatima","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wong, S.C., Kamarudin, M.N.A., and Naidu, R. (2021). Anticancer mechanism of curcumin on human glioblastoma. Nutrients, 13.","DOI":"10.3390\/nu13030950"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zoi, V., Galani, V., Vartholomatos, E., Zacharopoulou, N., Tsoumeleka, E., Gkizas, G., Bozios, G., Tsekeris, P., Chousidis, I., and Leonardos, I. (2021). Curcumin and radiotherapy exert synergistic anti-glioma effect in vitro. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111562"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s12031-020-01639-z","article-title":"Combination therapy with nanomicellar-curcumin and temozolomide for in vitro therapy of glioblastoma multiforme via Wnt signaling pathways","volume":"70","author":"Bagherian","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10835","DOI":"10.1080\/10408398.2023.2229433","article-title":"Advances in lipo-solubility delivery vehicles for curcumin: Bioavailability, precise targeting, possibilities and challenges","volume":"64","author":"Wen","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1039\/D3TB02485G","article-title":"Nanomedicine facilitated cell signaling blockade: Difficulties and strategies to overcome glioblastoma","volume":"12","author":"Habeeb","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32606","DOI":"10.1021\/acsomega.5c02206","article-title":"Nanotherapeutic Strategies for Overcoming the Blood\u2013Brain Barrier: Applications in Disease Modeling and Drug Delivery","volume":"10","author":"Kirit","year":"2025","journal-title":"ACS Omega"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Khatoon, S., and Kalam, N. (2025). Mechanistic insight of curcumin: A potential pharmacological candidate for epilepsy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1531288"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Musielak, E., and Krajka-Ku\u017aniak, V. (2025). Lipidic and Inorganic Nanoparticles for Targeted Glioblastoma Multiforme Therapy: Advances and Strategies. Micro, 5.","DOI":"10.3390\/micro5010002"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1021\/acsabm.4c01956","article-title":"Advancements in Using Polymeric Nanoparticles for Blood\u2013Brain Barrier Penetration in Neurological Disorders","volume":"8","author":"Wu","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1002\/ptr.7158","article-title":"Pleiotropic nature of curcumin in targeting multiple apoptotic-mediated factors and related strategies to treat gastric cancer: A review","volume":"35","author":"Shetty","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11596-024-2950-7","article-title":"Current combinatorial therapeutic aspects: The future prospect for glioblastoma treatment","volume":"44","author":"Gautam","year":"2024","journal-title":"Curr. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"33440","DOI":"10.18632\/oncotarget.7961","article-title":"PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108412","DOI":"10.1016\/j.abb.2020.108412","article-title":"Curcumin suppresses glioblastoma cell proliferation by p-AKT\/mTOR pathway and increases the PTEN expression","volume":"689","author":"Wang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zoi, V., Kyritsis, A.P., Galani, V., Lazari, D., Sioka, C., Voulgaris, S., and Alexiou, G.A. (2024). The role of curcumin in cancer: A focus on the PI3K\/Akt pathway. Cancers, 16.","DOI":"10.3390\/cancers16081554"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Rai, M., Pandit, R., Paralikar, P., Nagaonkar, D., Rehman, F., and Alves dos Santos, C. (2017). Pharmaceutical applications of curcumin-loaded nanoparticles. Nanotechnology Applied to Pharmaceutical Technology, Springer.","DOI":"10.1007\/978-3-319-70299-5_6"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/10799893.2020.1767649","article-title":"Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-\u039aB inhibition by suppressing IKK\u03b3 expression","volume":"40","author":"Deng","year":"2020","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13577-024-01112-8","article-title":"Immunomodulatory signalling networks in glioblastoma multiforme: A comprehensive review of therapeutic approaches","volume":"37","author":"Sarkar","year":"2024","journal-title":"Hum. Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-\u03baB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Piperi, C., Papavassiliou, K.A., and Papavassiliou, A.G. (2019). Pivotal role of STAT3 in shaping glioblastoma immune microenvironment. Cells, 8.","DOI":"10.3390\/cells8111398"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ame2.12491","article-title":"Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review","volume":"7","author":"Golmohammadi","year":"2024","journal-title":"Anim. Models Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, M., Wang, J., Song, Z., and Pei, Y. (2025). Regulation mechanism of curcumin mediated inflammatory pathway and its clinical application: A review. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1642248"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ryskalin, L., Biagioni, F., Busceti, C.L., Lazzeri, G., Frati, A., and Fornai, F. (2020). The multi-faceted effect of curcumin in glioblastoma from rescuing cell clearance to autophagy-independent effects. Molecules, 25.","DOI":"10.3390\/molecules25204839"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1870647","DOI":"10.1080\/23723556.2020.1870647","article-title":"Targeting gliomas with STAT3-silencing nanoparticles","volume":"8","author":"Kadiyala","year":"2021","journal-title":"Mol. Cell. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41420","DOI":"10.1038\/srep41420","article-title":"Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells","volume":"7","author":"Sidhar","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Salucci, S., Bavelloni, A., Stella, A.B., Fabbri, F., Vannini, I., Piazzi, M., Volkava, K., Scotlandi, K., Martinelli, G., and Faenza, I. (2023). The cytotoxic effect of curcumin in rhabdomyosarcoma is associated with the modulation of AMPK, AKT\/mTOR, STAT, and p53 signaling. Nutrients, 15.","DOI":"10.3390\/nu15030740"},{"key":"ref_35","first-page":"1397","article-title":"Modulating the p53-MDM2 pathway: The therapeutic potential of natural compounds in cancer treatment","volume":"23","author":"Ramli","year":"2024","journal-title":"EXCLI J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13273-020-00101-w","article-title":"Curcumin promotes oxidative stress, apoptosis and autophagy in H9c2 rat cardiomyoblasts","volume":"16","year":"2020","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.14202\/vetworld.2025.715-730","article-title":"In silico study of the potential of curcumin and its derivatives for increasing wild-type p53 expression and improving the function of p53 mutant R273H","volume":"18","author":"Nainggolan","year":"2025","journal-title":"Vet. World"},{"key":"ref_38","first-page":"e159105","article-title":"Investigating How Nano-Curcumin Affects the Expression of the p53 Gene and Inhibits the Cell Cycle in the A549 Lung Cancer Cell Line","volume":"16","author":"Salehi","year":"2025","journal-title":"Jentashapir J. Cell. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cui, J., Li, H., Zhang, T., Lin, F., Chen, M., Zhang, G., and Feng, Z. (2025). Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1548073"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41420-023-01578-9","article-title":"Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1051\/bmdcn\/2019090423","article-title":"Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: A comprehensive meta-analysis of randomized controlled trials","volume":"9","author":"Alizadeh","year":"2019","journal-title":"BioMedicine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tiv.2019.05.003","article-title":"Prodigiosin induces apoptosis and inhibits autophagy via the extracellular signal-regulated kinase pathway in K562 cells","volume":"60","author":"Ji","year":"2019","journal-title":"Toxicol. Vitr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Park, J.-Y., Choi, Y., Kim, H.-D., Kuo, H.-H., Chang, Y.-C., and Kim, C.-H. (2025). Matrix Metalloproteinases and Their Inhibitors in the Pathogenesis of Epithelial Differentiation, Vascular Disease, Endometriosis, and Ocular Fibrotic Pterygium. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125553"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wro\u0144ski, P., Wro\u0144ski, S., Kurant, M., Malinowski, B., and Wici\u0144ski, M. (2021). Curcumin may prevent basement membrane disassembly by matrix metalloproteinases and progression of the bladder cancer. Nutrients, 14.","DOI":"10.3390\/nu14010032"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Senft, C., Polacin, M., Priester, M., Seifert, V., K\u00f6gel, D., and Weissenberger, J. (2010). The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-491"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2014.12.044","article-title":"Autophagy inhibition improves the efficacy of curcumin\/temozolomide combination therapy in glioblastomas","volume":"358","author":"Braganhol","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yaroshenko, M., Christoff, M., \u015acibiorski, M., Surowiec, K., Jakubowicz-Gil, J., and Sumorek-Wiadro, J. (2025). Natural Compounds That Target Glioma Stem Cells. NeuroSci, 6.","DOI":"10.3390\/neurosci6020052"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2174\/0929867327666200228110738","article-title":"The \u201cBig Five\u201d phytochemicals targeting cancer stem cells: Curcumin, EGCG, sulforaphane, resveratrol and genistein","volume":"28","author":"Naujokat","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mattei, V., Santilli, F., Martellucci, S., Delle Monache, S., Fabrizi, J., Colapietro, A., Angelucci, A., and Festuccia, C. (2021). The importance of tumor stem cells in glioblastoma resistance to therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083863"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s13596-024-00800-y","article-title":"Curcumin and 2-DG synergistically target the glio-oncogenesis trigger IL-6 and down-regulate the stemness in glioblastoma model in-vitro","volume":"25","author":"Peter","year":"2025","journal-title":"Adv. Tradit. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsami.2c03538","article-title":"Nanomedicines targeting glioma stem cells","volume":"15","author":"Sabu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gersey, Z.C., Rodriguez, G.A., Barbarite, E., Sanchez, A., Walters, W.M., Ohaeto, K.C., Komotar, R.J., and Graham, R.M. (2017). Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3058-2"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.4103\/NRR.NRR-D-24-00048","article-title":"Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: Drug stability, targeting efficiency, and safety","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Rahman, M.A., Jalouli, M., Al-Zharani, M., Hoque Apu, E., and Harrath, A.H. (2025). Mechanistic Insights into Autophagy-Dependent Cell Death (ADCD): A Novel Avenue for Cancer Therapy. Cells, 14.","DOI":"10.3390\/cells14141072"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1002\/jcp.27404","article-title":"Curcumin: A naturally occurring autophagy modulator","volume":"234","author":"Shakeri","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2478\/acph-2020-0029","article-title":"Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K\/AKT\/mTOR signaling pathway","volume":"70","author":"Wang","year":"2020","journal-title":"Acta Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/auto.19471","article-title":"Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage","volume":"8","author":"Han","year":"2012","journal-title":"Autophagy"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Fabianowska-Majewska, K., Kaufman-Szymczyk, A., Szymanska-Kolba, A., Jakubik, J., Majewski, G., and Lubecka, K. (2021). Curcumin from turmeric rhizome: A potential modulator of DNA methylation machinery in breast cancer inhibition. Nutrients, 13.","DOI":"10.3390\/nu13020332"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40364-025-00788-w","article-title":"Epigenetic regulation of histone modifications in glioblastoma: Recent advances and therapeutic insights","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/cncr.25414","article-title":"Development of curcumin as an epigenetic agent","volume":"116","author":"Fu","year":"2010","journal-title":"Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Miles, F.L., Mashchak, A., Filippov, V., Orlich, M.J., Duerksen-Hughes, P., Chen, X., Wang, C., Siegmund, K., and Fraser, G.E. (2020). DNA methylation profiles of vegans and non-vegetarians in the adventist health study-2 cohort. Nutrients, 12.","DOI":"10.3390\/nu12123697"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00432-020-03432-2","article-title":"Experimental and clinical studies on radiation and curcumin in human glioma","volume":"147","author":"Sminia","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Amini, A., Khadivar, P., Ahmadnia, A., Alipour, M., Majeed, M., Jamialahmadi, T., Sathyapalan, T., and Sahebkar, A. (2021). Role of curcumin in regulating long noncoding RNA expression in cancer. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health, Springer.","DOI":"10.1007\/978-3-030-64872-5_2"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/biof.1776","article-title":"Targeting of the tumor microenvironment by curcumin","volume":"47","author":"Fu","year":"2021","journal-title":"Biofactors"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e70055","DOI":"10.1111\/acel.70055","article-title":"Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy","volume":"24","author":"Admasu","year":"2025","journal-title":"Aging Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1111\/cas.14675","article-title":"Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3","volume":"111","author":"Hayakawa","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jiang, M., Qi, Y., Huang, W., Lin, Y., and Li, B. (2022). Curcumin Reprograms TAMs from a protumor phenotype towards an antitumor phenotype via inhibiting MAO-A\/STAT6 Pathway. Cells, 11.","DOI":"10.3390\/cells11213473"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Parker, J.M., Zhao, L., Mayberry, T.G., Cowan, B.C., Wakefield, M.R., and Fang, Y. (2025). From Spice to Survival: The Emerging Role of Curcumin in Cancer Immunotherapy. Cancers, 17.","DOI":"10.3390\/cancers17152491"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12291-024-01279-9","article-title":"Combination Therapy of Curcumin and Cisplatin Encapsulated in Niosome Nanoparticles for Enhanced Oral Cancer Treatment","volume":"40","author":"Saberian","year":"2025","journal-title":"Indian. J. Clin. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zheng, B., and McClements, D.J. (2020). Formulation of More Efficacious Curcumin Delivery Systems Using Colloid Science: Enhanced Solubility, Stability, and Bioavailability. Molecules, 25.","DOI":"10.3390\/molecules25122791"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/08982104.2022.2086567","article-title":"Recent updates in curcumin delivery","volume":"33","author":"Obeid","year":"2023","journal-title":"J. Liposome Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/cpb.c19-00854","article-title":"Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis","volume":"68","author":"Tashima","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tifs.2019.04.017","article-title":"Application of curcumin-loaded nanocarriers for food, drug and cosmetic purposes","volume":"88","author":"Rafiee","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"ref_74","first-page":"e66669","article-title":"PEGylation in pharmaceutical development: Current status and emerging trends in macromolecular and immunotherapeutic drugs","volume":"16","author":"Santhanakrishnan","year":"2024","journal-title":"Cureus"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Larra\u00f1eta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R., and Donnelly, R.F. (2018). Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications. J. Funct. Biomater., 9.","DOI":"10.3390\/jfb9010013"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chopra, H., Dey, P.S., Das, D., Bhattacharya, T., Shah, M., Mubin, S., Maishu, S.P., Akter, R., Rahman, M.H., and Karthika, C. (2021). Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules, 26.","DOI":"10.3390\/molecules26164998"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Karatug Kacar, A., Sak, R., Nurdogan, A.N., Ergin K\u0131z\u0131lcay, G., and Bahadori, F. (2025). Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: A novel approach using esculetin and curcumin. Naunyn Schmiedebergs Arch. Pharmacol., 1\u201320.","DOI":"10.1007\/s00210-025-04455-7"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Hafez Ghoran, S., Calcaterra, A., Abbasi, M., Taktaz, F., Nieselt, K., and Babaei, E. (2022). Curcumin-based nanoformulations: A promising adjuvant towards cancer treatment. Molecules, 27.","DOI":"10.3390\/molecules27165236"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1039\/C7BM01088E","article-title":"A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model","volume":"6","author":"Tan","year":"2018","journal-title":"Biomater. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1208\/s12249-025-03185-6","article-title":"Solid Lipid Nanoparticles: An Innovative Drug Delivery System for Enhanced Bioavailability and Targeted Therapy","volume":"26","author":"Aggarwal","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1039\/D0BM01536A","article-title":"Development of curcumin-loaded zein nanoparticles for transport across the blood-brain barrier and inhibition of glioblastoma cell growth","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.7150\/thno.82005","article-title":"Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment","volume":"13","author":"Sampron","year":"2023","journal-title":"Theranostics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"19469","DOI":"10.18632\/oncotarget.3625","article-title":"Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway","volume":"6","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ciftci, F., \u00d6zarslan, A.C., Kantarci, I.C., Yelkenci, A., Tavukcuoglu, O., and Ghorbanpour, M. (2025). Advances in drug targeting, drug delivery, and nanotechnology applications: Therapeutic significance in cancer treatment. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010121"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2400232","DOI":"10.1002\/smsc.202400232","article-title":"Overcoming the Blood-Brain Barrier: Multifunctional Nanomaterial-Based Strategies for Targeted Drug Delivery in Neurological Disorders","volume":"4","author":"McLoughlin","year":"2024","journal-title":"Small Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1039\/C8TB02723D","article-title":"Design of dual drug-loaded dendrimer\/carbon dot nanohybrids for fluorescence imaging and enhanced chemotherapy of cancer cells","volume":"7","author":"Li","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Maiti, P., Scott, J., Sengupta, D., Al-Gharaibeh, A., and Dunbar, G.L. (2019). Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt\/mTOR Pathway in Cultured Glioblastoma Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020399"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Dhungel, L., Rowsey, M.E., Harris, C., and Raucher, D. (2024). Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy. Molecules, 29.","DOI":"10.3390\/molecules29040840"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Janaszewska, A., Lazniewska, J., Trzepi\u0144ski, P., Marcinkowska, M., and Klajnert-Maculewicz, B. (2019). Cytotoxicity of Dendrimers. Biomolecules, 9.","DOI":"10.3390\/biom9080330"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Cerqueira, R., Domingues, C., Veiga, F., Jarak, I., and Figueiras, A. (2024). Development and Characterization of Curcumin-Loaded TPGS\/F127\/P123 Polymeric Micelles as a Potential Therapy for Colorectal Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147577"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Raucher, D., Dragojevic, S., and Ryu, J. (2018). Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00624"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","article-title":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Dragoj, M., Stojkovska, J., Stankovi\u0107, T., Dini\u0107, J., Podolski-Reni\u0107, A., Obradovi\u0107, B., and Pe\u0161i\u0107, M. (2021). Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing. Brain Sci., 11.","DOI":"10.3390\/brainsci11081025"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","article-title":"Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain","volume":"320","author":"Israel","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1039\/D5NA00376H","article-title":"Engineered dual-functional gold nanoparticles enhance radiosensitization in prostate cancer cells: Synergistic action of curcumin and gold","volume":"7","author":"Aborig","year":"2025","journal-title":"Nanoscale Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1039\/D5RA00728C","article-title":"Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: A review","volume":"15","author":"Ghazi","year":"2025","journal-title":"RSC Adv."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Alharbi, S.K., Alsehli, B.R., AlSuhaimi, A.O., Thumayri, K.A., AlMohaimadi, K.M., Mehdar, Y.T.H., Almalki, M.A., and Hussein, B.H.M. (2025). Mesoporous Silica Nanoparticles Functionalized with Bisphenol A for Dispersive Solid-Phase Extraction of 3-Chloroaniline from Water Matrices: Material Synthesis and Sorption Optimization. Nanomater., 15.","DOI":"10.3390\/nano15231751"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Song, J., Lu, C., Leszek, J., and Zhang, J. (2021). Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810118"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Li, C., Zhou, L., and Yin, X. (2024). Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1342181"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Ghorai, S.M., Deep, A., Magoo, D., Gupta, C., and Gupta, N. (2023). Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB). Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071999"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Paul, A., Collins, M.G., and Lee, H.Y. (2022). Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders. Front. Genome Ed., 4.","DOI":"10.3389\/fgeed.2022.899209"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2024051822","article-title":"Polymeric Nanoparticles Revolutionizing Brain Cancer Therapy: A Comprehensive Review of Strategies and Advances","volume":"42","author":"Wahengbam","year":"2025","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10787-025-01643-y","article-title":"Targeting mTOR with curcumin: Therapeutic implications for complex diseases","volume":"33","author":"Khayatan","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41065-023-00269-w","article-title":"Identification of autophagy-related genes in neuropathic pain through bioinformatic analysis","volume":"160","author":"Tian","year":"2023","journal-title":"Hereditas"},{"key":"ref_105","first-page":"325","article-title":"Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas","volume":"20","author":"Wang","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhou, W., Jia, Y., Liu, Y., Chen, Y., and Zhao, P. (2022). Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112346"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Wahnou, H., El Kebbaj, R., Liagre, B., Sol, V., Limami, Y., and Duval, R.E. (2025). Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010114"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10787-025-01666-5","article-title":"A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules","volume":"33","author":"Afshari","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3892\/or.2014.3342","article-title":"Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT\/mTOR signaling","volume":"32","author":"Yin","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jrr\/rrac016","article-title":"Interaction of curcumin with glioblastoma cells via high and low linear energy transfer radiation therapy inducing radiosensitization effects","volume":"63","author":"Kim","year":"2022","journal-title":"J. Radiat. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/med.21876","article-title":"Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets","volume":"42","author":"Zhong","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"El-Saadony, M.T., Yang, T., Korma, S.A., Sitohy, M., Abd El-Mageed, T.A., Selim, S., Al Jaouni, S.K., Salem, H.M., Mahmmod, Y., and Soliman, S.M. (2022). Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1040259"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1021\/acs.molpharmaceut.5c00504","article-title":"Smart Nanometals: An Approach to Transform Brain Cancer Diagnosis and Therapy","volume":"22","author":"Arora","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12672-025-02471-w","article-title":"Modulation of the PI3K\/Akt signaling pathway by resveratrol in cancer: Molecular mechanisms and therapeutic opportunity","volume":"16","author":"Hedayati","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1871527321666220404180944","article-title":"Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase","volume":"22","author":"Rao","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_116","first-page":"163","article-title":"Curcumin in Combination with Other Adjunct Therapies for Brain Tumor Treatment: Existing Knowledge and Blueprint for Future Research","volume":"10","author":"Peter","year":"2021","journal-title":"Int. J. Mol. Cell Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13318-019-00545-z","article-title":"Enhancing Curcumin Oral Bioavailability Through Nanoformulations","volume":"44","author":"Ipar","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/1061186X.2024.2389892","article-title":"Advancements in curcumin-loaded PLGA nanoparticle delivery systems: Progressive strategies in cancer therapy","volume":"32","author":"Koushki","year":"2024","journal-title":"J. Drug Target."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Zoi, V., Galani, V., Tsekeris, P., Kyritsis, A.P., and Alexiou, G.A. (2022). Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020312"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1002\/jcp.27442","article-title":"Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Tagde, P., Tagde, P., Islam, F., Tagde, S., Shah, M., Hussain, Z.D., Rahman, M.H., Najda, A., Alanazi, I.S., and Germoush, M.O. (2021). The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders. Molecules, 26.","DOI":"10.3390\/molecules26237109"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1381612825666190313123704","article-title":"Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme","volume":"25","author":"Shahcheraghi","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"108404","DOI":"10.1016\/j.exppara.2022.108404","article-title":"Nanocurcumin as an adjuvant in killed Toxoplasma gondii vaccine formulation: An experience in BALB\/c mice","volume":"243","author":"Ajami","year":"2022","journal-title":"Exp. Parasitol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1002308","DOI":"10.37349\/etat.2025.1002308","article-title":"Nanoimmunotherapy: The smart trooper for cancer therapy","volume":"6","author":"Parveen","year":"2025","journal-title":"Explor. Target. Antitumor Ther."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Chimento, A., D\u2019Amico, M., De Luca, A., Conforti, F.L., Pezzi, V., and De Amicis, F. (2023). Resveratrol, Epigallocatechin Gallate and Curcumin for Cancer Therapy: Challenges from Their Pro-Apoptotic Properties. Life, 13.","DOI":"10.3390\/life13020261"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3656419","DOI":"10.1155\/2020\/3656419","article-title":"Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis","volume":"2020","author":"Rainey","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Bolat, Z.B., Islek, Z., Demir, B.N., Yilmaz, E.N., Sahin, F., and Ucisik, M.H. (2020). Curcumin- and Piperine-Loaded Emulsomes as Combinational Treatment Approach Enhance the Anticancer Activity of Curcumin on HCT116 Colorectal Cancer Model. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00050"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: Problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Stohs, S.J., Chen, O., Ray, S.D., Ji, J., Bucci, L.R., and Preuss, H.G. (2020). Highly Bioavailable Forms of Curcumin and Promising Avenues for Curcumin-Based Research and Application: A Review. Molecules, 25.","DOI":"10.3390\/molecules25061397"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Silvestre, F., Santos, C., Silva, V., Ombredane, A., Pinheiro, W., Andrade, L., Garcia, M., Pacheco, T., Joanitti, G., and Luz, G. (2023). Pharmacokinetics of Curcumin Delivered by Nanoparticles and the Relationship with Antitumor Efficacy: A Systematic Review. Pharm., 16.","DOI":"10.3390\/ph16070943"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Achar, A., Myers, R., and Ghosh, C. (2021). Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121834"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2310\/JIM.0b013e318271fb3b","article-title":"Translational research challenges: Finding the right animal models","volume":"60","author":"Prabhakar","year":"2012","journal-title":"J. Investig. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e2502315","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape","volume":"21","author":"Desai","year":"2025","journal-title":"Small"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ibrahim, K.E., Al-Mutary, M.G., Bakhiet, A.O., and Khan, H.A. (2018). Histopathology of the Liver, Kidney, and Spleen of Mice Exposed to Gold Nanoparticles. Molecules, 23.","DOI":"10.3390\/molecules23081848"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Cacciola, N.A., Cuciniello, R., Petillo, G.D., Piccioni, M., Filosa, S., and Crispi, S. (2023). An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612587"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1470-2045(18)30096-2","article-title":"Combining precision radiotherapy with molecular targeting and immunomodulatory agents: A guideline by the American Society for Radiation Oncology","volume":"19","author":"Bristow","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jsps.2021.09.015","article-title":"Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumab","volume":"29","author":"Hermawan","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Okada, S., Vaeteewoottacharn, K., and Kariya, R. (2019). Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models. Cells, 8.","DOI":"10.20944\/preprints201906.0002.v1"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Karthikeyan, A., Senthil, N., and Min, T. (2020). Nanocurcumin: A Promising Candidate for Therapeutic Applications. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00487"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Olivier, M., Asmis, R., Hawkins, G.A., Howard, T.D., and Cox, L.A. (2019). The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194781"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/0115665240309647240516042716","article-title":"Emerging Insights into the PI3K\/AKT\/mTOR Signaling Pathway and Non-Coding RNA-mediated Drug Resistance in Glioblastoma","volume":"25","author":"Shimia","year":"2025","journal-title":"Curr. Mol. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/0118722105244482231017102857","article-title":"Applications of Nanomedicine in Brain Tumor Therapy: Nanocarrierbased Drug Delivery Platforms, Challenges, and Perspectives","volume":"19","author":"Verma","year":"2025","journal-title":"Recent. Pat. Nanotechnol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/194\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:26:04Z","timestamp":1767936364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":142,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["nu18020194"],"URL":"https:\/\/doi.org\/10.3390\/nu18020194","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}